Pharmacokinetics of the Protease Inhibitor Indinavir in Human Immunodeficiency Virus Type 1-Infected Children

The objective of this study was to evaluate the pharmacokinetics of indinavir in human immunodeficiency virus-infected children as part of a prospective, open, uncontrolled, multicenter study in The Netherlands. Human immunodeficiency virus type 1-infected children were monitored over 6 months of tr...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Burger, David M., van Rossum, Annemarie M. C., Hugen, Patricia W. H., Suur, Marja H., Hartwig, Nico G., Geelen, Sibyl P. M., Scherpbier, Henriette J., Hoetelmans, Richard M. W., Vulto, Arnold G., de Groot, Ronald
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Pharmacology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90359/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11181346/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.3.701-705.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!